ZACNP1

Across TCGA pan-cancer cohorts, ZACNP1 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated ZACNP1 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher ZACNP1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ZACNP1 expression acts as an unfavorable survival marker.

OV, LIHC, and STAD are the cancer types where ZACNP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	II,III,IV	0.647	0.852	.006	54	view →
LIHC	DFS	Tertile	All	0.099	0.546	<.001	54	view →
STAD	DFS	Tertile	All	0.486	0.738	.012	30	view →
SKCM	DFS	Tertile	IV	0.036	0.433	<.001	9	view →
COAD	DFS	Tertile	All	0.297	0.693	.027	9	view →
THCA	OS	Tertile	II,III,IV	0.240	0.830	.002	9	view →
SARC	OS	Tertile	All	0.216	0.618	.001	9	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

ZACNP1–OV (OS)

Open the OV breakdown →